Pluri Inc. SEC filings PLUR
Pluri Inc. has 953 filings in SEC EDGAR's recent list, going back to Sep 10, 2001. Its latest annual report, Form 10-K, was filed on Sep 10, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (material agreement, unregistered share sale, other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 15, 2026 |
| DEF 14A | Proxy statement | May 27, 2025 | Jun 30, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 25, 2025 | May 23, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 14, 2025 | May 14, 2025 |
| DEF 14A | Proxy statement | May 1, 2024 | Jun 25, 2024 |
| DEF 14A | Proxy statement | Feb 27, 2023 | Apr 27, 2023 |
| PRE 14A | Preliminary proxy statement | Feb 16, 2023 | Feb 16, 2023 |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 21, 2022 |
| DEF 14A | Proxy statement | Apr 8, 2021 | Jun 1, 2021 |
| DEFA14A | Additional proxy material | May 20, 2020 | — |
| DEF 14A | Proxy statement | May 20, 2020 | Jun 29, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 30, 2020 | Apr 30, 2020 |
| DEFA14A | Additional proxy material | Apr 26, 2019 | — |
| DEF 14A | Proxy statement | Apr 25, 2019 | Apr 25, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 15, 2019 | Apr 15, 2019 |
| DEFA14A | Additional proxy material | Apr 3, 2018 | — |
| DEF 14A | Proxy statement | Apr 3, 2018 | Apr 3, 2018 |
| DEFA14A | Additional proxy material | Mar 30, 2017 | — |
| DEF 14A | Proxy statement | Mar 30, 2017 | Mar 30, 2017 |
| DEFA14A | Additional proxy material | Apr 4, 2016 | — |
| DEF 14A | Proxy statement | Apr 4, 2016 | Apr 4, 2016 |
| DEFA14A | Additional proxy material | Apr 2, 2015 | — |
| DEF 14A | Proxy statement | Apr 2, 2015 | Apr 2, 2015 |
| DEFA14A | Additional proxy material | Mar 31, 2014 | — |
| DEF 14A | Proxy statement | Mar 31, 2014 | Mar 31, 2014 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2014 | Mar 18, 2014 |
| DEFA14A | Additional proxy material | Mar 29, 2013 | — |
| DEF 14A | Proxy statement | Mar 29, 2013 | Mar 29, 2013 |
| DEF 14A | Proxy statement | Mar 22, 2012 | Mar 22, 2012 |
| DEFA14A | Additional proxy material | May 16, 2011 | — |
| DEF 14A | Proxy statement | Apr 15, 2011 | Apr 15, 2011 |
| DEF 14A | Proxy statement | Nov 23, 2009 | Nov 23, 2009 |
| PRE 14A | Preliminary proxy statement | Nov 10, 2009 | Nov 10, 2009 |
| DEF 14A | Proxy statement | Dec 29, 2008 | Dec 29, 2008 |
| DEF 14A | Proxy statement | Jun 2, 2008 | Jun 2, 2008 |
| PRE 14A | Preliminary proxy statement | May 20, 2008 | May 20, 2008 |
| DEF 14C | Information statement | Mar 31, 2008 | Mar 31, 2008 |
| PRE 14C | Filing | Mar 20, 2008 | Mar 20, 2008 |
| DEF 14A | Proxy statement | Jan 13, 2004 | Jan 13, 2004 |
| DEF 14C | Information statement | Jun 4, 2003 | May 21, 2003 |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PLUR (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Haifa
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1158780
- Former names
- PLURISTEM THERAPEUTICS INC (until Jul 13, 2022); PLURISTEM LIFE SYSTEMS INC (until Dec 28, 2007); AI SOFTWARE INC (until Jul 1, 2003)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.